Heights Capital Management, Inc Pro Mis Neurosciences Inc. Transaction History
Heights Capital Management, Inc
- $213 Billion
- Q1 2025
A detailed history of Heights Capital Management, Inc transactions in Pro Mis Neurosciences Inc. stock. As of the latest transaction made, Heights Capital Management, Inc holds 18,267 shares of PMN stock, worth $14,796. This represents 0.01% of its overall portfolio holdings.
Number of Shares
18,267
Previous 160,207
88.6%
Holding current value
$14,796
Previous $152 Million
91.49%
% of portfolio
0.01%
Previous 0.08%
Shares
3 transactions
Others Institutions Holding PMN
# of Institutions
19Shares Held
9.4MCall Options Held
0Put Options Held
0-
Great Point Partners LLC Greenwich, CT2.65MShares$2.14 Million1.14% of portfolio
-
Armistice Capital, LLC New York, NY2.33MShares$1.89 Million0.02% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L31.93MShares$1.56 Million0.36% of portfolio
-
Ally Bridge Group (Ny) LLC New York, NY1.48MShares$1.2 Million1.37% of portfolio
-
Altium Capital Management LP New York, NY574KShares$465,1401.38% of portfolio
About ProMIS Neurosciences Inc.
- Ticker PMN
- Exchange OTC
- Description
- ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...